Search research articles
Contact Us
Filters
Showing results (151-160 of 232) with videos related to
Page
of 24
Sort By:
Cell Host & Microbe
|
June 5, 2018
Multi-Donor Longitudinal Antibody Repertoire Sequencing Reveals the Existence of Public Antibody Clonotypes in HIV-1 Infection
Ian Setliff, Wyatt J McDonnell, Nagarajan Raju, et al.
Journal of Virology
|
December 12, 2023
Development of LIBRA-seq for the guinea pig model system as a tool for the evaluation of antibody responses to multivalent HIV-1 vaccines
Matthew J Vukovich, Nagarajan Raju, Prudence Kgagudi, et al.
Biorxiv : the Preprint Server for Biology
|
June 8, 2021
Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking
Andrea R Shiakolas, Nicole Johnson, Kevin J Kramer, et al.
Cell
|
April 2, 2013
Somatic mutations of the immunoglobulin framework are generally required for broad and potent HIV-1 neutralization
Florian Klein, Ron Diskin, Johannes F Scheid, et al.
Journal of Virology
|
March 20, 2015
Sustained Delivery of a Broadly Neutralizing Antibody in Nonhuman Primates Confers Long-Term Protection against Simian/Human Immunodeficiency Virus Infection
Kevin O Saunders, Amarendra Pegu, Ivelin S Georgiev, et al.
Nature Biotechnology
|
March 4, 2022
Efficient discovery of SARS-CoV-2-neutralizing antibodies via B cell receptor sequencing and ligand blocking
Andrea R Shiakolas, Kevin J Kramer, Nicole V Johnson, et al.
Pathogens & Immunity
|
January 2, 2020
Crystal Structure and Immunogenicity of the DS-Cav1-Stabilized Fusion Glycoprotein From Respiratory Syncytial Virus Subtype B
M Gordon Joyce, Amy Bao, Man Chen, et al.
Cell Reports. Medicine
|
November 7, 2023
SARS-CoV-2 antibodies from children exhibit broad neutralization and belong to adult public clonotypes
Steven C Wall, Naveenchandra Suryadevara, Changil Kim, et al.
Frontiers in Immunology
|
January 10, 2022
Polyclonal Broadly Neutralizing Antibody Activity Characterized by CD4 Binding Site and V3-Glycan Antibodies in a Subset of HIV-1 Virus Controllers
Tinashe E Nyanhete, Robert J Edwards, Celia C LaBranche, et al.
Journal of Virology
|
March 10, 2017
Structure-Based Design of a Soluble Prefusion-Closed HIV-1 Env Trimer with Reduced CD4 Affinity and Improved Immunogenicity
Gwo-Yu Chuang, Hui Geng, Marie Pancera, et al.
Page
of 24
Search research articles
Search
Showing results (151-160 of 232) with videos related to
Sort By:
Page
of 24
Cell Host & Microbe
|
June 5, 2018
Multi-Donor Longitudinal Antibody Repertoire Sequencing Reveals the Existence of Public Antibody Clonotypes in HIV-1 Infection
Ian Setliff, Wyatt J McDonnell, Nagarajan Raju, et al.
Journal of Virology
|
December 12, 2023
Development of LIBRA-seq for the guinea pig model system as a tool for the evaluation of antibody responses to multivalent HIV-1 vaccines
Matthew J Vukovich, Nagarajan Raju, Prudence Kgagudi, et al.
Biorxiv : the Preprint Server for Biology
|
June 8, 2021
Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking
Andrea R Shiakolas, Nicole Johnson, Kevin J Kramer, et al.
Cell
|
April 2, 2013
Somatic mutations of the immunoglobulin framework are generally required for broad and potent HIV-1 neutralization
Florian Klein, Ron Diskin, Johannes F Scheid, et al.
Journal of Virology
|
March 20, 2015
Sustained Delivery of a Broadly Neutralizing Antibody in Nonhuman Primates Confers Long-Term Protection against Simian/Human Immunodeficiency Virus Infection
Kevin O Saunders, Amarendra Pegu, Ivelin S Georgiev, et al.
Nature Biotechnology
|
March 4, 2022
Efficient discovery of SARS-CoV-2-neutralizing antibodies via B cell receptor sequencing and ligand blocking
Andrea R Shiakolas, Kevin J Kramer, Nicole V Johnson, et al.
Pathogens & Immunity
|
January 2, 2020
Crystal Structure and Immunogenicity of the DS-Cav1-Stabilized Fusion Glycoprotein From Respiratory Syncytial Virus Subtype B
M Gordon Joyce, Amy Bao, Man Chen, et al.
Cell Reports. Medicine
|
November 7, 2023
SARS-CoV-2 antibodies from children exhibit broad neutralization and belong to adult public clonotypes
Steven C Wall, Naveenchandra Suryadevara, Changil Kim, et al.
Frontiers in Immunology
|
January 10, 2022
Polyclonal Broadly Neutralizing Antibody Activity Characterized by CD4 Binding Site and V3-Glycan Antibodies in a Subset of HIV-1 Virus Controllers
Tinashe E Nyanhete, Robert J Edwards, Celia C LaBranche, et al.
Journal of Virology
|
March 10, 2017
Structure-Based Design of a Soluble Prefusion-Closed HIV-1 Env Trimer with Reduced CD4 Affinity and Improved Immunogenicity
Gwo-Yu Chuang, Hui Geng, Marie Pancera, et al.
Page
of 24